<- Go Home
Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Market Cap
N/A
Volume
398.4K
Cash and Equivalents
$652.7M
EBITDA
$591.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.9B
Profit Margin
71.90%
52 Week High
$628.92
52 Week Low
N/A
Dividend
N/A
Price / Book Value
20.08
Price / Earnings
26.45
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
18.14
Operating Income
$562.9M
Return on Equity
77.25%
Return on Assets
17.47
Cash and Short Term Investments
$652.7M
Debt
$146.1M
Equity
$598.3M
Revenue
$2.7B
Unlevered FCF
$490.7M
Sector
Life Sciences Tools and Services
Category
N/A